These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 8796616)
1. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging. Saini S; Edelman RR; Li W; Petersein J; Hahn PF Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616 [No Abstract] [Full Text] [Related]
2. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222 [TBL] [Abstract][Full Text] [Related]
3. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver. Balzer T; Carter EC; Shamsi K; Niendorf HP Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619 [No Abstract] [Full Text] [Related]
4. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM; Kim CS; Youk JH; Lee MS Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629 [TBL] [Abstract][Full Text] [Related]
5. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI]. Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107 [TBL] [Abstract][Full Text] [Related]
6. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles. Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710 [No Abstract] [Full Text] [Related]
7. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047 [TBL] [Abstract][Full Text] [Related]
8. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Clément O; Siauve N; Cuénod CA; Frija G Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405 [TBL] [Abstract][Full Text] [Related]
10. [Overview of MRI contrast media. The case of endorem]. Duroux M Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029 [No Abstract] [Full Text] [Related]
11. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis. Macarini L; Marini S; Murrone M; Ettorre GC Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693 [TBL] [Abstract][Full Text] [Related]
12. Relaxation effects of clustered particles. Tanimoto A; Oshio K; Suematsu M; Pouliquen D; Stark DD J Magn Reson Imaging; 2001 Jul; 14(1):72-7. PubMed ID: 11436217 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
14. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography]. Pleger B; Beyer HK; Laufer U Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872 [No Abstract] [Full Text] [Related]
15. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [TBL] [Abstract][Full Text] [Related]
16. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?]. Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049 [TBL] [Abstract][Full Text] [Related]
17. SPIO-MRI in the detection of hepatocellular carcinoma. Araki T J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500 [No Abstract] [Full Text] [Related]
18. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem]. Vogl TJ; Hammerstingl R; Keck H; Felix R Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]